Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1David A. Barbie, William C. Hahn, Pablo Tamayo et al.|Nature|2009Cited by 4.2k
Defining T Cell States Associated with Response to Checkpoint Immunotherapy in MelanomaMoshe Sade-Feldman, Nir Hacohen, Keren Yizhak et al.|Cell|2018Cited by 2k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby‐Arnon, Charles H. Yoon, Parin Shah et al.|Cell|2018Cited by 1.5k
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumorsDiana Miao, Eliezer M. Van Allen, Claire A. Margolis et al.|Nature Genetics|2018Cited by 701
Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicineEliezer M. Van Allen, Levi A. Garraway, Nikhil Wagle et al.|Nature Medicine|2014Cited by 571